Despite some limitations, clinic-based CrAg LFA screening for HIV-infected adults with participants with CD4 < 200 cells/mm3 may be an important tool to help accelerate diagnosis and treatment of HIV-associated cryptococcal infections in order to reduce HIV-associated cryptococcal mortality. This evidence concerns the gene CD4 and cryptococcosis.